Cannabiomed, Inc. – Trademark Portfolio
Entity Type: 03
Cannabiomed, Inc. has 10 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO). Notable registered marks include CANNABIOMED. The portfolio includes 3 registered trademarks. Filings span 4 Nice Classification classes, led by Class 5 (Pharmaceuticals) and Class 35 (Advertising & Business). This trademark owner is based in Carson City, NV.
123 W. Nye Lane, Suite 129
Carson City, NV 89706
Showing of trademarks Trademarks
Trademark Classifications
Cannabiomed, Inc.'s trademark portfolio spans 4 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Advertising; business management; business administration; office functions
Scientific and technological services; industrial analysis and research services
Medical services; veterinary services; hygienic and beauty care for human beings or animals
Frequently Asked Questions
How many trademarks does Cannabiomed, Inc. have?
Cannabiomed, Inc. has 10 U.S. trademarks filed with the USPTO. Of these, 3 registered, 7 abandoned.
What trademark classes does Cannabiomed, Inc. file in?
Cannabiomed, Inc. files trademarks across 4 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 35 (Advertising & Business), Class 42 (Computer & Scientific), Class 44 (Medical Services). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.
What are Cannabiomed, Inc.'s most well-known trademarks?
Cannabiomed, Inc.'s registered trademark portfolio includes well-known marks such as CANNABIOMED. These are among 3 currently registered trademarks in the portfolio.
What is Cannabiomed, Inc.'s trademark registration success rate?
Cannabiomed, Inc. has a 30% trademark registration rate, with 3 out of 10 resolved applications resulting in successful registration. Currently, 0 applications are pending review.